MOLECULAR MECHANISMS OF RETINA-SPECIFIC GENE EXPRESSION

视网膜特异性基因表达的分子机制

基本信息

  • 批准号:
    6476380
  • 负责人:
  • 金额:
    $ 29.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-12-01 至 2004-11-30
  • 项目状态:
    已结题

项目摘要

Differential expression of genes is fundamental to biological processes. It is accomplished by the combinatorial and synergistic (or antagonistic) action of a relatively small number of transcription factors. To elucidate transcriptional regulatory mechanisms in the retina, it is essential to identify specific activators (and repressors) and delineate how these regulators integrate the signaling pathways with basal transcription machinery to generate a transcriptional response. We have previously identified Nrl, a transcription factor of the basic motif-leucine zipper (bZIP) family, by subtraction cloning. Nrl regulates rhodopsin promoter activity synergistically with Crx, a photoreceptor-specific transcription factor. Mutations in the human CRX or NRL gene result in photoreceptor degeneration, suggesting a major role for these two transcription factors in modulating photoreceptor gene expression in vivo. Our studies also reveal that Nrl interacts with Crx, TATA-binding protein, and other as yet uncharacterized proteins in the retina. Because of its unique expression pattern, possible regulation by FGF-2, and involvement in rhodopsin regulation, Nrl appears to be a key mediator of transcriptional response in the developing and mature retina. We hypothesize that interaction of Nrl with other regulatory proteins in the context of DNA-binding sequences is responsible for spatial and temporal control of gene expression in the retina. The goals of this proposal are to identify Nrl- interacting proteins (NIPs) in the retina using genetic (yeast two-hybrid) and biochemical (immuno- and DNA-affinity chromatography) methods, with a focus on delineating rhodopsin regulation (Aims 1-3). To assess the role of Nrl in developing retina, we propose to isolate NIPs from fetal retinal libraries by a yeast two-hybrid approach (Aim 2) and directly examine Nrl function in mice using a gene-knockout strategy (Aim 4). Elucidation of transcriptional regulatory pathways should reveal significant new insights into retinal development and disease. Since mutations in retinal transcription factors and their target genes result in retinopathies, it might be possible to experimentally manipulate the function of specific transcription factor(s) to up- or down-regulate a particular target gene and correct a disease phenotype.
基因的差异表达是生物过程的基础。它是通过相对少量的转录因子的组合和协同(或拮抗)作用来完成的。为了阐明视网膜中的转录调控机制,识别特定的激活物(和抑制物)并描述这些调控因子如何将信号通路与基础转录机制结合以产生转录反应是至关重要的。我们已经通过消减克隆的方法鉴定了NRL,它是一个碱性基序亮氨酸拉链(BZIP)家族的转录因子。NRL与光感受器特异性转录因子CRX协同调节视紫红质启动子活性。人CRX或NRL基因突变导致光感受器变性,提示这两种转录因子在体内调节光感受器基因表达方面发挥重要作用。我们的研究还发现,NRL与CRX、TATA结合蛋白以及视网膜中其他尚未鉴定的蛋白相互作用。由于其独特的表达模式,可能受成纤维细胞生长因子-2的调节,以及参与视紫红质的调节,NRL似乎是发育和成熟的视网膜转录反应的关键介质。我们假设,在DNA结合序列的背景下,NRL与其他调控蛋白的相互作用负责视网膜基因表达的空间和时间控制。这项建议的目标是使用遗传(酵母双杂交)和生化(免疫和DNA亲和层析)方法识别视网膜中的NRL相互作用蛋白(NIP),重点描述视紫红质调节(目标1-3)。为了评估NRL在视网膜发育中的作用,我们建议通过酵母双杂交方法从胚胎视网膜文库中分离NIP(目标2),并使用基因敲除策略直接检测小鼠的NRL功能(目标4)。转录调控途径的阐明将揭示对视网膜发育和疾病的重要新见解。由于视网膜转录因子及其靶基因的突变导致视网膜病变,因此有可能通过实验操纵特定转录因子(S)的功能来上调或下调特定的靶基因,并纠正疾病的表型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANAND SWAROOP其他文献

ANAND SWAROOP的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANAND SWAROOP', 18)}}的其他基金

MICROARRAY AND MOLECULAR BIOLOGY MODULE
微阵列和分子生物学模块
  • 批准号:
    7286539
  • 财政年份:
    2007
  • 资助金额:
    $ 29.48万
  • 项目类别:
Genetic Variations in Age-related Macular Degeneration
年龄相关性黄斑变性的遗传变异
  • 批准号:
    7094436
  • 财政年份:
    2006
  • 资助金额:
    $ 29.48万
  • 项目类别:
MOLECULAR GENETICS OF RETINAL DEVELOPMENT AND INHERITED EYE DISEASE
视网膜发育和遗传性眼病的分子遗传学
  • 批准号:
    6113354
  • 财政年份:
    1998
  • 资助金额:
    $ 29.48万
  • 项目类别:
MOLECULAR GENETICS OF RETINAL DEVELOPMENT AND INHERITED EYE DISEASE
视网膜发育和遗传性眼病的分子遗传学
  • 批准号:
    6297131
  • 财政年份:
    1998
  • 资助金额:
    $ 29.48万
  • 项目类别:
MOLECULAR GENETICS OF RETINAL DEVELOPMENT AND INHERITED EYE DISEASE
视网膜发育和遗传性眼病的分子遗传学
  • 批准号:
    6274588
  • 财政年份:
    1997
  • 资助金额:
    $ 29.48万
  • 项目类别:
MOLECULAR GENETICS OF RETINAL DEVELOPMENT AND INHERITED EYE DISEASE
视网膜发育和遗传性眼病的分子遗传学
  • 批准号:
    6244531
  • 财政年份:
    1997
  • 资助金额:
    $ 29.48万
  • 项目类别:
MOLECULAR MECHANISMS OF RETINA SPECIFIC GENE EXPRESSION
视网膜特异性基因表达的分子机制
  • 批准号:
    2608669
  • 财政年份:
    1996
  • 资助金额:
    $ 29.48万
  • 项目类别:
Molecular Mechanisms of Retina-specific Gene Expression
视网膜特异性基因表达的分子机制
  • 批准号:
    7171799
  • 财政年份:
    1996
  • 资助金额:
    $ 29.48万
  • 项目类别:
MOLECULAR MECHANISMS OF RETINA-SPECIFIC GENE EXPRESSION
视网膜特异性基因表达的分子机制
  • 批准号:
    6693055
  • 财政年份:
    1996
  • 资助金额:
    $ 29.48万
  • 项目类别:
MOLECULAR MECHANISMS OF RETINA SPECIFIC GENE EXPRESSION
视网膜特异性基因表达的分子机制
  • 批准号:
    2019993
  • 财政年份:
    1996
  • 资助金额:
    $ 29.48万
  • 项目类别:

相似海外基金

NOVEL RNASE PROTECTION ASSAY FOR CYTOKINE MRNAS
细胞因子 MRNAS 的新型 RNA 酶保护测定
  • 批准号:
    6317727
  • 财政年份:
    2000
  • 资助金额:
    $ 29.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了